Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness

This publication has 36 references indexed in Scilit:

• Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines
  International Journal of Radiation Oncology*Biology*Physics, 1996
• The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules
  Radiotherapy and Oncology, 1994
• Use of Fluorescencein SituHybridization to Measure Chromosome Aberrations as a Predictor of Radiosensitivity in Human Tumour Cells
  International Journal of Radiation Biology, 1994
• De novo cisplatinum resistance does not influence cellular radiosensitivity
  European Journal Of Cancer, 1993
• Intratumoral heterogeneity of malignant gliomas measured in vitro
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Radiosensitivityin Vitroof Human Soft Tissue Sarcoma Cell Lines and Skin Fibroblasts Derived from the Same Patients
  International Journal of Radiation Biology, 1993
• Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity
  The Lancet, 1992
• The prediction of human tumor radiosensitivity in situ: An approach using chromosome aberrations detected by fluorescence in situ hybridization
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Inherent radio sensitivity testing of tumor biopsies obtained from patients with carcinoma of the cervix or endometrium
  Radiotherapy and Oncology, 1991
• Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1985